Market Cap 232.64M
Revenue (ttm) 92.13M
Net Income (ttm) -18.66M
EPS (ttm) N/A
PE Ratio 31.90
Forward PE 34.96
Profit Margin -20.25%
Debt to Equity Ratio 0.23
Volume 180,500
Avg Vol 276,104
Day's Range N/A - N/A
Shares Out 18.64M
Stochastic %K 7%
Beta 1.10
Analysts Strong Sell
Price Target $24.33

Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awa...

Industry: Health Information Services
Sector: Healthcare
Phone: 248 651 6568
Address:
260 Charles Street, Suite 302, Waltham, United States
KingdomKing
KingdomKing Dec. 25 at 12:17 PM
$OPRX A transition phase is underway where operating consistency matters more than rapid expansion. Cash generation and unit economics need to converge with strategy for the thesis to mature. Any disconnect between guidance and results will be magnified by sentiment. Future re‑rating depends on tightening the gap between narrative and reality.
1 · Reply
tilance
tilance Dec. 24 at 4:13 PM
$OPRX opened a position here today...
1 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 1:57 PM
$OPRX Share Price: $12.77 Contract Selected: Mar 20, 2026 $10 Calls Buy Zone: $8.45 – $10.44 Target Zone: $15.57 – $19.03 Potential Upside: 74% ROI Time to Expiration: 92 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
HappyStockholder
HappyStockholder Dec. 2 at 4:22 PM
$OPRX Is this the deadest board on Stocktwits?
2 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:43 PM
0 · Reply
HappyStockholder
HappyStockholder Nov. 18 at 7:32 PM
$OPRX I know the market has gone sour, but OPRX started going down before that, and seems to be picking up speed. Buying opportunity or falling knife?
0 · Reply
JarvisFlow
JarvisFlow Nov. 17 at 12:55 PM
Stephens & Co. has adjusted their stance on OptimizeRx ( $OPRX ), setting the rating to Equal-Weight with a target price of 20 → 17.
0 · Reply
HappyStockholder
HappyStockholder Nov. 12 at 12:53 PM
$OPRX Strange price action since stellar earnings results, raised outlook, and several analyst price target increases. I have taken this opportunity to open an investment here.
0 · Reply
sofocles
sofocles Nov. 7 at 3:02 PM
$OPRX GREAT QUARTER RESULTS. JUST A MATTER OF TIME FOR RECOVERY
0 · Reply
DARKP00L
DARKP00L Nov. 7 at 2:24 PM
$OPRX 09:07 on Nov. 07 2025 Citizens Maintains Market Outperform on OptimizeRx, Raises Price Target to $24 #tradeideas
0 · Reply
Latest News on OPRX
4 Top AI-Powered Healthcare Stocks

Oct 9, 2025, 5:00 AM EDT - 2 months ago

4 Top AI-Powered Healthcare Stocks

BSX VEEV ZEPP


OptimizeRx: How The Stock Is Changing Pharma Marketing

Oct 7, 2025, 10:02 PM EDT - 2 months ago

OptimizeRx: How The Stock Is Changing Pharma Marketing


OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:26 PM EDT - 5 months ago

OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript


OptimizeRx: Stock Could Rise As Profitability Is Achieved

Jul 18, 2025, 3:47 PM EDT - 5 months ago

OptimizeRx: Stock Could Rise As Profitability Is Achieved


OptimizeRx to Participate in Upcoming Investor Conferences

May 16, 2025, 7:30 AM EDT - 8 months ago

OptimizeRx to Participate in Upcoming Investor Conferences


OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:56 PM EDT - 8 months ago

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 11:04 AM EDT - 10 months ago

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:58 PM EST - 1 year ago

OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript

May 14, 2024, 11:21 PM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript


OptimizeRx Reports First Quarter 2024 Financial Results

May 14, 2024, 4:01 PM EDT - 1 year ago

OptimizeRx Reports First Quarter 2024 Financial Results


OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 11:20 AM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript


KingdomKing
KingdomKing Dec. 25 at 12:17 PM
$OPRX A transition phase is underway where operating consistency matters more than rapid expansion. Cash generation and unit economics need to converge with strategy for the thesis to mature. Any disconnect between guidance and results will be magnified by sentiment. Future re‑rating depends on tightening the gap between narrative and reality.
1 · Reply
tilance
tilance Dec. 24 at 4:13 PM
$OPRX opened a position here today...
1 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 1:57 PM
$OPRX Share Price: $12.77 Contract Selected: Mar 20, 2026 $10 Calls Buy Zone: $8.45 – $10.44 Target Zone: $15.57 – $19.03 Potential Upside: 74% ROI Time to Expiration: 92 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
HappyStockholder
HappyStockholder Dec. 2 at 4:22 PM
$OPRX Is this the deadest board on Stocktwits?
2 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:43 PM
0 · Reply
HappyStockholder
HappyStockholder Nov. 18 at 7:32 PM
$OPRX I know the market has gone sour, but OPRX started going down before that, and seems to be picking up speed. Buying opportunity or falling knife?
0 · Reply
JarvisFlow
JarvisFlow Nov. 17 at 12:55 PM
Stephens & Co. has adjusted their stance on OptimizeRx ( $OPRX ), setting the rating to Equal-Weight with a target price of 20 → 17.
0 · Reply
HappyStockholder
HappyStockholder Nov. 12 at 12:53 PM
$OPRX Strange price action since stellar earnings results, raised outlook, and several analyst price target increases. I have taken this opportunity to open an investment here.
0 · Reply
sofocles
sofocles Nov. 7 at 3:02 PM
$OPRX GREAT QUARTER RESULTS. JUST A MATTER OF TIME FOR RECOVERY
0 · Reply
DARKP00L
DARKP00L Nov. 7 at 2:24 PM
$OPRX 09:07 on Nov. 07 2025 Citizens Maintains Market Outperform on OptimizeRx, Raises Price Target to $24 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 1:59 PM
Citizens has updated their rating for OptimizeRx ( $OPRX ) to Market Outperform with a price target of 24.
0 · Reply
Doozio
Doozio Oct. 26 at 9:23 PM
$OPRX MLYS gonna become BILI’s before 🐒🍌🧠⏰♾️ ends?
0 · Reply
sofocles
sofocles Oct. 24 at 5:35 PM
$OPRX any news here?
0 · Reply
MaverikIT
MaverikIT Oct. 14 at 8:51 PM
$OPRX - trying to break out
0 · Reply
WrappedLunatic
WrappedLunatic Oct. 7 at 12:41 AM
$OPRX yikes
0 · Reply
LayerOne
LayerOne Oct. 5 at 3:52 PM
$OPRX Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.
0 · Reply
sirspanky
sirspanky Oct. 3 at 7:30 PM
$HCTI 🚀 Bullish quick hits • Platform traction: QuantumNexis on Ezovion has processed $20M$37M projected usage; gateway adds a take-rate lever (recurring fees). • Valuation gap: Trading near micro-cap lows while our base-case math pencils $5$6.5/sh on conservative EV/Sales vs peers. • Runway improved: Recent cash in from warrant exercises extends operations and funds growth. • Multi-region scale: India/KSA/Malaysia expansion + marketplace routes make onboarding easier. • Catalysts ahead: Gateway go-live, new logos, regulatory/commercial updates. Bottom line: execution + multiple expansion is the setup. Watching $3 reclaim next. Peers to watch: $OPRX $HIMS #DigitalHealth #AIinHealthcare
0 · Reply
sirspanky
sirspanky Oct. 2 at 3:06 PM
$HCTI Cliffs after the dip • Why it fell: Warrant inducement = quick cash now (~$1.63M) but near-term dilution. New share count ≈ 6.75M. • Where we stand: At $2.54, implied EV ≈ $9.2M vs $12–14M revenue → only 0.6–0.8× EV/Sales (micro-cap peers often 2.0–3.5×). • Fair value math: Base case ~$6.47/sh (post-deal). Even if all new $3 warrants exercise later, FV still ~$6.10/sh (fully diluted). • Execution tailwinds: QuantumNexis/Ezovion $20M processed → $37M guide; payment gateway adds a take-rate monetization lever. • Watch next: 8-K terms, gateway go-live, regional wins (India/KSA/MY), new logos. Bottom line: The deal stung, but cash runway improved and valuation is well below conservative comps. If execution continues, multiple expansion is the story. $HCTI $OPRX $HIMS (Not financial advice.)
0 · Reply
sirspanky
sirspanky Oct. 2 at 2:10 PM
$HCTI 🚀 QuantumNexis Milestone on Ezovion EMR: $20M processed in usage-based revenue, guiding to $37M in coming months + integrated payment gateway on deck. This is real platform throughput + a clear path to monetize volume (take-rate) across India, Bangladesh, KSA, Malaysia. Why it matters: • Proof of adoption → recurring, higher-margin potential • Fintech rails = new revenue lever (fees) • Expansion across multiple regions = durability, not one-off If execution continues, multiple expansion becomes the story. Watching for gateway rollout, new logos, and marketplace wins. Peers to watch: $RCM $OPRX $HIMS
0 · Reply
MaverikIT
MaverikIT Sep. 29 at 9:21 PM
$OPRX +1.12
0 · Reply
wellsmccormick
wellsmccormick Sep. 18 at 2:11 PM
$OPRX This is not tech theater. NXXT delivers uptime that clinics and towns bank on. Expect PRs highlighting saves and contracts locking multiyear revenue.
0 · Reply
Doozio
Doozio Sep. 5 at 10:11 AM
EXTReme $OPRT unties with no huckleberries still in $OPRX during 🐒🍌🧠⏰♾️
0 · Reply